Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India
Table 3
Risk factors for mucormycosis among never-hospitalised COVID-19 patients, multi-centric case-control study of post-COVID rhino-orbito-cerebral mucormycosis, India, 2021.